
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Donna Cassidy-Hanley is senior research associate at the department of Microbiology & Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).

Published: October 2nd 2010 | Updated: